KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Debt Ratio: 2017-2024

Historic Debt Ratio for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Dec 2024 value amounting to 0.68.

  • Amneal Pharmaceuticals' Debt Ratio rose 3.35% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 3.35%. This contributed to the annual value of 0.68 for FY2024, which is 7.75% down from last year.
  • Amneal Pharmaceuticals' Debt Ratio amounted to 0.68 in FY2024, which was down 7.75% from 0.74 recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Debt Ratio ranged from a high of 0.74 in FY2023 and a low of 0.68 during FY2024.
  • Its 3-year average for Debt Ratio is 0.71, with a median of 0.70 in 2022.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Debt Ratio increased by 5.82% in 2023 and then dropped by 7.75% in 2024.
  • Amneal Pharmaceuticals' Debt Ratio (Yearly) stood at 0.69 in 2020, then fell by 0.20% to 0.69 in 2021, then rose by 0.81% to 0.70 in 2022, then grew by 5.82% to 0.74 in 2023, then dropped by 7.75% to 0.68 in 2024.